India launches probe as Chinese company recalls BP drug - (The Economic Times via NewsPoints Desk)

  • India's drug controller has initiated an investigation against all companies importing valsartan for commonly used hypertension drugs from Chinese manufacturer Zhejiang Huahai Pharmaceuticals, reported The Economic Times.

  • The move follows the recent recall of medicines containing valsartan in several countries, including the US, Germany and Italy, amid reports that an ingredient used in valsartin's manufacturing by this particular company carries a "potential cancer risk."

  • Regulatory agencies, including the FDA and the European Medicines Agency, have started a review of medicines containing the active substance valsartan.

  • FirstWord Reports: Providing insight, analysis and expert opinion on important Pharma trends and challenging issues <Click here>

To read more NewsPoints articles, click here.

Reference Articles